|
1
|
Al Dahhan SA and Al Lami FH: Epidemiology
of Colorectal Cancer in Iraq, 2002–2014. Gulf J Oncolog. 1:23–26.
2018.PubMed/NCBI
|
|
2
|
Abdulla MH, Valli-Mohammed MA, Al-Khayal
K, Al Shkieh A, Zubaidi A, Ahmad R, Al-Saleh K, Al-Obeed O and
McKerrow J: Cathepsin B expression in colorectal cancer in a Middle
East population: Potential value as a tumor biomarker for late
disease stages. Oncol Rep. 37:3175–3180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vatandoust S, Price TJ and Karapetis CS:
Colorectal cancer: Metastases to a single organ. World J
Gastroenterol. 21:11767–11776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li CX, An XX, Zhao B, Wu SJ, Xie GH and
Fang XM: Impact of operation timing on post-operative infections
following colorectal cancer surgery. ANZ J Surg. 86:294–298. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katsidzira L, Gangaidzo I, Thomson S,
Rusakaniko S, Matenga J and Ramesar R: The shifting epidemiology of
colorectal cancer in sub-Saharan Africa. Lancet Gastroenterol
Hepatol. 2:377–383. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Legrand N, Dixon DA and Sobolewski C:
AU-rich element-binding proteins in colorectal cancer. World J
Gastrointest Oncol. 11:71–90. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Govaert JA, van Dijk WA, Fiocco M,
Scheffer AC, Gietelink L, Wouters MW and Tollenaar RA: Nationwide
outcomes measurement in colorectal cancer surgery: Improving
quality and reducing costs. J Am Coll Surg. 222:19–29.e2. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Curtis NJ, Taylor M, Fraser L, Salib E,
Noble E, Hipkiss R, Allison AS, Dalton R, Ockrim JB and Francis NK:
Can the combination of laparoscopy and enhanced recovery improve
long-term survival after elective colorectal cancer surgery? Int J
Colorectal Dis. 33:231–234. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Obad S, dos Santos CO, Petri A, Heidenblad
M, Broom O, Ruse C, Fu C, Lindow M, Stenvang J, Straarup EM, et al:
Silencing of microRNA families by seed-targeting tiny LNAs. Nat
Genet. 43:371–378. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhome R, Del Vecchio F, Lee G-H, Bullock
MD, Primrose JN, Sayan AE and Mirnezami AH: Exosomal microRNAs
(exomiRs): Small molecules with a big role in cancer. Cancer Lett.
420:228–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhai W, Li S, Zhang J, Chen Y, Ma J, Kong
W, Gong D, Zheng J, Xue W and Xu Y: Sunitinib-suppressed miR-452-5p
facilitates renal cancer cell invasion and metastasis through
modulating SMAD4/SMAD7 signals. Mol Cancer. 17:1572018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu L, Chen K, Wu J, Shi L, Hu B, Cheng S,
Li M and Song L: Downregulation of miR-452 promotes stem-like
traits and tumorigenicity of gliomas. Clin Cancer Res.
19:3429–3438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He Z, Xia Y, Pan C, Ma T, Liu B, Wang J,
Chen L and Chen Y: Up-regulation of MiR-452 inhibits metastasis of
non-small cell lung cancer by regulating BMI1. Cell Physiol
Biochem. 37:387–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang C, Chen Q, Li S, Li S, Zhao Z, Gao H,
Wang X, Li B, Zhang W, Yuan Y, et al: Dual inhibition of PCDH9
expression by miR-215-5p up-regulation in gliomas. Oncotarget.
8:10287–10297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simon K: Colorectal cancer development and
advances in screening. Clin Interv Aging. 11:967–976. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ling H, Pickard K, Ivan C, Isella C, Ikuo
M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, et al: The
clinical and biological significance of MIR-224 expression in
colorectal cancer metastasis. Gut. 65:977–989. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang S, Sun Z, Zhou Q, Wang W, Wang G,
Song J, Li Z, Zhang Z, Chang Y, Xia K, et al: MicroRNAs, long
noncoding RNAs, and circular RNAs: Potential tumor biomarkers and
targets for colorectal cancer. Cancer Manag Res. 10:2249–2257.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolter JM, Le HH, Linse A, Godlove VA,
Nguyen TD, Kotagama K, Lynch A, Rawls A and Mangone M: Evolutionary
patterns of metazoan microRNAs reveal targeting principles in the
let-7 and miR-10 families. Genome Res. 27:53–63. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei W, Yang Y, Cai J, Cui K, Li RX, Wang
H, Shang X and Wei D: miR-30a-5p suppresses tumor metastasis of
human colorectal cancer by targeting ITGB3. Cell Physiol Biochem.
39:1165–1176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gan XN, Gan TQ, He RQ, Luo J, Tang RX,
Wang HL, Zhou H, Qing H, Ma J, Hu XH, et al: Clinical significance
of high expression of miR-452-5p in lung squamous cell carcinoma.
Oncol Lett. 15:6418–6430. 2018.PubMed/NCBI
|
|
23
|
Kolligs FT: Diagnostics and Epidemiology
of Colorectal Cancer. Visc Med. 32:158–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ullmann P, Nurmik M, Schmitz M, Rodriguez
F, Weiler J, Qureshi-Baig K, Felten P, Nazarov PV, Nicot N, Zuegel
N, et al: Tumor suppressor miR-215 counteracts hypoxia-induced
colon cancer stem cell activity. Cancer Lett. 450:32–41. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bouvier AM and Launoy G: Epidemiology of
colorectal cancer. Rev Prat. 65:767–773. 2015.(In French).
PubMed/NCBI
|
|
26
|
Gao L, Gan XN, Ye ZH, et al: MiR-452-5p
may serve as an oncogene in colorectal cancer through targeting
CDKN1B: A study based on bioinformatics analysis and
dual-luciferase reporter assay. Int J Clin Exp Med. 12:2151–2166.
2019.
|
|
27
|
Vychytilova-Faltejskova P, Merhautova J,
Machackova T, Gutierrez-Garcia I, Garcia-Solano J, Radova L,
Brchnelova D, Slaba K, Svoboda M, Halamkova J, et al: MiR-215-5p is
a tumor suppressor in colorectal cancer targeting EGFR ligand
epiregulin and its transcriptional inducer HOXB9. Oncogenesis.
6:3992017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He Z, Xia Y, Liu B, Qi X, Li Z, Wang J,
Chen L and Chen Y: Down-regulation of miR-452 is associated with
poor prognosis in the non-small-cell lung cancer. J Thorac Dis.
8:894–900. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Halvorsen AR, Sandhu V, Sprauten M, Flote
VG, Kure EH, Brustugun OT and Helland Å: Circulating microRNAs
associated with prolonged overall survival in lung cancer patients
treated with nivolumab. Acta Oncol. 57:1225–1231. 2018. View Article : Google Scholar : PubMed/NCBI
|
